[20191122]LSB10364_减少伤害或促进药物滥用?根据联邦毒品法监管注射场所.pdf

上传人:任我行 文档编号:28686 上传时间:2022-06-24 发布时间:2019-11-22 格式:PDF 页数:5 大小:656.47KB
下载 相关 举报
[20191122]LSB10364_减少伤害或促进药物滥用?根据联邦毒品法监管注射场所.pdf_第1页
第1页 / 共5页
[20191122]LSB10364_减少伤害或促进药物滥用?根据联邦毒品法监管注射场所.pdf_第2页
第2页 / 共5页
[20191122]LSB10364_减少伤害或促进药物滥用?根据联邦毒品法监管注射场所.pdf_第3页
第3页 / 共5页
[20191122]LSB10364_减少伤害或促进药物滥用?根据联邦毒品法监管注射场所.pdf_第4页
第4页 / 共5页
[20191122]LSB10364_减少伤害或促进药物滥用?根据联邦毒品法监管注射场所.pdf_第5页
第5页 / 共5页
亲,该文档总共5页,全部预览完了,如果喜欢就下载吧!
资源描述

1、CRS Legal Sidebar Prepared for Members and Committees of Congress Legal SidebarLegal Sidebari i Reducing Harm or Enabling Substance Abuse? Supervised Injection Sites Under Federal Drug Law November 22, 2019 To mitigate the effects of the opioid crisis in Philadelphia, in 2018 a nonprofit called Safe

2、house announced plans to open a supervised injection site where illicit drug users could consume opioids under the supervision of trained staff, receive medical intervention in case of an overdose, and access services including addiction treatment. The U.S. Department of Justice (DOJ) sued Safehouse

3、 to block the proposed facility, arguing that the supervised injection site would violate a provision of the Controlled Substances Act (CSA) known as the “crack house statute,” which prohibits making facilities available “for the purpose of unlawfully . . . using a controlled substance.” On October

4、2, 2019, a district court judge in United States v. Safehouse ruled that the planned facility would not violate the CSA because the provision in question does not apply to supervised injection sites such as Safehouse. The district courts ruling could have significant implications for supervised inje

展开阅读全文
相关资源
猜你喜欢
相关搜索
资源标签

当前位置:首页 > 法规条令 > CRS 美国国会研究处报告